FT Health: Combating Coronavirus

As researchers race to develop a coronavirus vaccine, we look at efforts to ensure that the world’s poor are not left behind — and ask whether the pandemic will jolt policymakers into confronting the looming threat from antimicrobial resistance

Will poor countries get the coronavirus treatments they need?
Pharma and its critics agree government has a big role to play in ensuring fair access to Covid-19 remedies
Coronavirus lessons for the fight against ‘superbugs’
The world needs to act now to avert the threat from antimicrobial resistance
Drugmakers race to scale up vaccine capacity
Funding bodies face a choice between established manufacturers and biotech upstarts
The coronavirus pandemic is moment of truth for anti-vaccine movement
Hardcore activists resist vaccinations but Covid-19 sharpens the dilemma for waverers
Big Pharma calls for ‘billions’ in upfront coronavirus funding
CEOs also urge nations to co-ordinate competing requests and to avoid repeat of Ebola failure
Coronavirus puts Big Pharma’s IP regime to the test
The race is on to find treatments — but who will own the resulting knowhow?